Finance Forum

Mission:

To build relationships between and among financial professionals throughout the BioNJ Membership and the NJ life sciences ecosystem to foster educational and professional community, information sharing and peer to peer collaboration to facilitate scientific and medical advancement through financial stewardship. Committee members plan and host interactive forums meaningful to its constituents on a variety of topics.

Committee Members

Adastra Pharmaceuticals, Inc. – Scott Megaffin, CEO
ADMA Biologics, Inc. – Brian Lenz, CPA, Executive Vice President & CFO
EisnerAmper LLP – John Pennett, CPA, Partner-in-Charge, National Life Sciences & Technology Group
EY – Tony Torrington, CPA, Partner
EY – Joel Wagner, CPA, Senior Manager
EY – Arda Ural, MSc, MBA, Ph.D., Partner, Life Sciences, Transaction Advisory Services
Genmab – Anthony Pagano, MBA, MSc, Senior Vice President, Global Finance
Hepion Pharmaceuticals, Inc. – John Cavan, MBA, MSc, CFO
IVERIC bio, Inc. – Dave Carroll, CFO
Katten Muchin Rosenman LLP – Jason Vigna, JD, Partner
Katten Muchin Rosenman LLP – Jonathan Rotenberg, JD, Partner
Matinas Biopharma Holdings, Inc. – Keith Kucinski, CPA, CFO
Ovid Therapeutics – Tim Daly, Sr. Vice President, Finance & Corporate Controller
Pepper Hamilton LLP – Tim Atkins, JD, Partner
PricewaterhouseCoopers LLP – Chris Pierce, CPA, Partner
PricewaterhouseCoopers LLP – Michael Bey, MBA, Partner
Signum Biosciences, Inc. – Michael Losch, MBA, CFO